Show simple item record

dc.contributor.authorSpritzer, Poli Marapt_BR
dc.contributor.authorRamos, Ramon Bossardipt_BR
dc.contributor.authorMarchesan, Lucas Bandeirapt_BR
dc.contributor.authorOliveira, Mônica dept_BR
dc.contributor.authorCarmina, Enricopt_BR
dc.date.accessioned2021-04-08T04:17:28Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn1758-5996pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/219602pt_BR
dc.description.abstractBackground: Polycystic ovary syndrome (PCOS) is a common endocrine disease affecting women of reproductive age and associated with reproductive and metabolic dysfunction. Few studies are available regarding metabolic traits in Brazilian women with PCOS. The aim of this systematic review and meta-analysis was to summarize the available evidence regarding metabolic traits and comorbidities in Brazilian women with polycystic ovary syndrome (PCOS). Methods: We systematically searched PubMed, Cochrane Central Register of Controlled Trials, and Embase for cross-sectional, case–control, or cohort studies focusing on populations of different regions from Brazil, published until July 31, 2019. Studies were selected if they reported PCOS diagnostic criteria. Studies without a control group were included if they presented relevant metabolic data. Results: Of 4856 studies initially identified, 27 were included in the systematic review and 12 were included in the meta-analysis, for a total of 995 women with PCOS defined by Rotterdam criteria and 2275 controls from different regions of Brazil. Obesity, metabolic syndrome and IGT were prevalent, and standard mean differences for BMI (SMD 0.67, 95% CI, 0.29, 1.05), waist circumference (SMD 0.22, 95% CI 0.02, 0.41), systolic (SMD 0.66, 95% CI 0.30, 1.01) and diastolic blood pressure (SMD 0.55, 95% CI 0.24, 0.87), glucose (SMD 0.21, 95% CI 0.04, 0.38) and HOMA (SMD 0.78, 95% CI 0.52, 1.04) were significantly higher in Brazilian women with PCOS compared to controls. Lipid profile was more adverse in PCOS vs. non-PCOS women. Between-study heterogeneities were low/moderate for glucose and HOMA and moderate/high for the other variables. Conclusions: The data of this systematic review and meta-analysis indicate that Brazilian women with PCOS have a worse metabolic profile than women without PCOS with no important regional differences. The prevalence of metabolic changes is intermediate in Brazil vs. other countries.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofDiabetology & metabolic syndrome. [London]. Vol. 13 (2021), 18, 16 p.pt_BR
dc.rightsOpen Accessen
dc.subjectPolycystic ovary syndromeen
dc.subjectSíndrome do ovário policísticopt_BR
dc.subjectMetabolismopt_BR
dc.subjectObesityen
dc.subjectBlood pressureen
dc.subjectMulherespt_BR
dc.subjectInsulin resistanceen
dc.subjectRevisão sistemáticapt_BR
dc.subjectMetabolic abnormalitiesen
dc.subjectBrazilen
dc.titleMetabolic profile of women with PCOS in Brazil : a systematic review and meta-analysispt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001123721pt_BR
dc.type.originEstrangeiropt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record